Maternal mental health begins with first medication for postnatal depression treatment, with postnatal depression affecting approximately one in seven new mothers.
NPR's Mary Louise Kelly speaks with Dr. Kristina M. Deligiannidis, principal investigator on the clinical trials that led to the FDA approval of the first at-home oral postpartum depression pill.
In national clinical trials, led by the Feinstein Institutes for Medical Research in Manhasset, patients showed relief from their symptoms in just a few days and sustained benefits for several weeks.